Virtual Panel Discussion

Virtual Panel Discussion

Register for Virtual Panel Discussion

April 13, 2023 | 12:00 pm Central
Register Now

Join us for a virtual panel discussion on the impact of synthetic drug and novel psychoactive substance use on clinical care in healthcare settings.

Our panelists will cover several relevant topics, including:

  • Impact and risk of synthetic drug use, including novel psychoactive substances, on individuals in the inpatient and outpatient settings
  • Frequency with which individuals unknowingly encounter synthetic drugs prior to receipt of treatment in either an inpatient or outpatient setting
  • Significance of understanding an individual’s recent use of synthetic drugs or drug use trends in your geography
  • Expectations as to how changes in substances circulating within the drug supply will continue to impact care decisions moving forward

Panelists include:

Ryan S. Alexander, D.O., MPH
Addiction Medicine Physician at McNabb Center in Knoxville, TN
Clinical Faculty at LMU-DeBusk College of Osteopathic Medicine and University of Tennessee Graduate School of Medicine

Ryan Feldman, Pharm.D., BCPS, DABAT
Clinical Assistant Professor, Department of Clinical Sciences at Medical College of Wisconsin

Leigh Brooks, APRN, FNP-C
OBMAT Medical Director at Bluestone Primary Care

Joshua Schrecker, Pharm.D.
Director, Clinical Affairs, Aegis Sciences Corporation